Soleus Capital Management, L.P. Horizon Therapeutics Public LTD CO Transaction History

Soleus Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $6.18 Million - $9.06 Million	77,842 New	77,842 $6.21 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $909,008 - $1.21 Million	-12,655 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $2.65 Million - $3.34 Million	-39,572 Reduced 75.77%	12,655 $926,000
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $1.25 Million - $1.81 Million	22,627 Added 76.44%	52,227 $4.06 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $893,920 - $1.69 Million	29,600 New	29,600 $1.65 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.